Molina Healthcare Inc (MOH, Financial) is set to release its Q3 2024 earnings on Oct 24, 2024. The consensus estimate for Q3 2024 revenue is $9.92 billion, and the earnings are expected to come in at $5.47 per share. The full year 2024's revenue is expected to be $39.79 billion and the earnings are expected to be $21.15 per share. More detailed estimate data can be found on the Forecast page.
Molina Healthcare Inc (MOH, Financial) Estimates Trends
Over the past 90 days, revenue estimates for Molina Healthcare Inc (MOH) for the full year 2024 have increased from $39.69 billion to $39.79 billion, and for 2025, from $42.56 billion to $42.57 billion. Earnings estimates have shown a decline, with forecasts for 2024 decreasing from $21.86 per share to $21.15 per share, and for 2025, from $24.98 per share to $24.48 per share.
Molina Healthcare Inc (MOH, Financial) Reported History
In the previous quarter of June 30, 2024, Molina Healthcare Inc's (MOH) actual revenue was $9.88 billion, which beat analysts' revenue expectations of $9.75 billion by 1.37%. Molina Healthcare Inc's (MOH) actual earnings were $5.17 per share, which beat analysts' earnings expectations of $5.144 per share by 0.51%. After releasing the results, Molina Healthcare Inc (MOH) was up by 12.28% in one day.
Molina Healthcare Inc (MOH, Financial) 12 Month Price Targets
Based on the one-year price targets offered by 14 analysts, the average target price for Molina Healthcare Inc (MOH) is $372.65 with a high estimate of $406 and a low estimate of $335. The average target implies an upside of 31.23% from the current price of $283.96.
Based on GuruFocus estimates, the estimated GF Value for Molina Healthcare Inc (MOH, Financial) in one year is $452.23, suggesting an upside of 59.26% from the current price of $283.96.
Based on the consensus recommendation from 17 brokerage firms, Molina Healthcare Inc's (MOH, Financial) average brokerage recommendation is currently 2.6, indicating a "Hold" status. The rating scale ranges from 1 to 5, where 1 signifies Strong Buy, and 5 denotes Sell.
This article, generated by GuruFocus, is designed to provide general insights and is not tailored financial advice. Our commentary is rooted in historical data and analyst projections, utilizing an impartial methodology, and is not intended to serve as specific investment guidance. It does not formulate a recommendation to purchase or divest any stock and does not consider individual investment objectives or financial circumstances. Our objective is to deliver long-term, fundamental data-driven analysis. Be aware that our analysis might not incorporate the most recent, price-sensitive company announcements or qualitative information. GuruFocus holds no position in the stocks mentioned herein.
